Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-04-05FDA Approved: FASENRA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for FASENRA (benralizumab) from AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Telecommunication Enhanced Asthma Management [NA]
Completed clinical trial investigating telecommunication-enhanced asthma management; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: Exacerbation Risk in Asthma
A completed clinical trial update on exacerbation risk in asthma with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma [Phase 3]
Phase 3 clinical trial evaluating a triple therapy using magnetic resonance imaging in asthma has posted results; the study is currently not…
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma [Phase 3]
Phase 3 trial comparing Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX vs SYMBICORT TURBOHALER in adults with asthma; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma [Phase 2]
Phase 2 proof-of-concept study of rilzabrutinib in adults with moderate-to-severe asthma has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: BenRalizumab Effect on Airway Remodeling in Severe asTHma [Phase 4]
Phase 4 clinical trial evaluating benralizumab's effect on airway remodeling in severe asthma with eosinophilic features; recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Study of CM310 in Subjects With Moderate to Severe Asthma [Phase 2]
Phase 2 clinical trial of CM310 in moderate to severe asthma has been completed.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: REVErsing Airway Remodelling With Tezepelumab [Phase 3]
Phase 3 clinical trial evaluating tezepelumab for reversing airway remodeling in asthmatic patients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics [Phase 1]
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of GSK3923868 inhalation powder in healthy participants and stable asthma…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Telemedicine Enhanced Asthma Management Through the Emergency Department [NA]
A completed clinical trial from the University of Rochester evaluated telemedicine-enhanced asthma management in the emergency department, w…
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults [Phase 2]
Phase 2 trial evaluating gamma tocopherol-enriched supplement on lower airway responses to inhaled wood smoke in healthy adults; study compl…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma [Phase 2]
Phase 2 trial assessing MEDI3506 in adults with uncontrolled moderate-to-severe asthma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID [Phase 4]
Phase 4 trial update evaluating the incidence of local adverse effects in the oropharyngeal and laryngeal region with Advair DISKUS 250/50 m…
-
FDA approval · 2024-01-25FDA Approved: DUPIXENT — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Dupixent (dupilumab) filed by Sanofi‑Aventis U.S. LLC, indicating an approval of a supplement re…
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma [Phase 4]
Phase 4 trial evaluating dose escalation of reslizumab in patients with severe eosinophilic asthma.
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: Effect of a Synbiotic "Probiotical®/Bactecal® " in Asthma [Phase 2, Phase 3]
Phase 2/3 trial update evaluating a synbiotic (Probiotical/Bactecal) in asthma.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) [Phase 2]
Phase 2 clinical trial update on BenRAlizumab for acute exacerbations in asthma and COPD (the ABRA Study).
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: AZithromycin Against pLacebo in Exacerbations of Asthma [Phase 4]
Phase 4 clinical trial evaluating azithromycin versus placebo in exacerbations of asthma has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Clinical Response to Rhinovirus Challenge [Phase 2]
Phase 2 clinical trial assessing clinical response to rhinovirus challenge in participants with asthma and allergic rhinitis has completed w…
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma [Phase 1]
A Phase 1 pharmacokinetics study of tezepelumab in children with asthma has completed, with results posted in 2024.
-
FDA approval · 2024-01-05FDA Approved: DEXAMETHASONE INTENSOL — Supplemental Application (Hikma Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for DEXAMETHASONE INTENSOL from Hikma Pharmaceuticals USA, Inc., a dexamethasone product.
-
FDA approval · 2023-12-28FDA Approved: EPINEPHRINE — Supplemental Application (BPI Labs, LLC)
The FDA has approved a supplemental application for epinephrine filed by BPI Labs, LLC under the existing NDA. The approval authorizes chang…
-
FDA approval · 2023-12-19FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the supplemental application for Fluticasone Propionate and Salmeterol from Hikma Pharmaceuticals USA Inc., confirming a supple…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: A Study of CM326 in Subjects With Moderate to Severe Asthma [Phase 2]
Phase 2 clinical trial update for CM326 in adults with moderate to severe asthma.